Solomon Martin Shenker

Title: Solomon Martin Shenker: Innovator in Immunotherapy

Introduction

Solomon Martin Shenker is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunotherapy, holding a total of 9 patents. His work focuses on enhancing the efficacy of immune effector cells, which play a crucial role in treating various diseases, including cancer.

Latest Patents

One of his latest patents is titled "Gene-regulating compositions and methods for improved immunotherapy." This patent provides methods and compositions related to the modification of immune effector cells to increase therapeutic efficacy. In some embodiments, immune effector cells are modified to reduce the expression of one or more endogenous target genes or to reduce one or more functions of an endogenous protein. This modification enhances the effector functions of the immune cells. Additionally, the patent describes immune effector cells that are further modified by the introduction of transgenes conferring antigen specificity, such as exogenous T cell receptors (TCRs) or chimeric antigen receptors (CARs). Methods of treating cell proliferative disorders, such as cancer, using these modified immune effector cells are also provided.

Career Highlights

Solomon Shenker is currently associated with Ksq Therapeutics, Inc., where he continues to innovate in the field of immunotherapy. His work has been instrumental in advancing therapeutic strategies that leverage the body's immune system to combat diseases.

Collaborations

Some of his notable coworkers include Micah Benson and Jason J Merkin, who collaborate with him on various projects aimed at improving immunotherapeutic approaches.

Conclusion

Solomon Martin Shenker's contributions to immunotherapy through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments that harness the power of the immune system.